Integration of Artificial Intelligence into the Approach for Diagnosis and Monitoring of Dry Eye Disease

An efficient enhanced stacked auto encoder assisted optimized deep neural network for forecasting Dry Eye Disease

Meibomian Gland Dysfunction (MGD) and Dry Eye Disease (DED) comprise two of the most significant eye diseases, impacting millions of sufferers worldwide. Several etiological factors influence the early symptoms of DED. Early diagnosis and treatment of erectile dysfunction may significantly improve the Quality of Life (QoL) for people. The current study introduces the ESAE-ODNN, an improved stacked autoencoder-aided optimised deep neural network, as a new way to predict DED using feature selection (FS), feature extraction (FE), and classification. The approach described here is novel because it merges chaotic maps into FS, employs SLSTM-STSA for improved classification accuracy (CA), and optimizes with the adaptive quantum rotation of the Enhanced Quantum Bacterial Foraging Optimisation Algorithm (EQBFOA). The present study enhances prediction functions by extracting MGD-related features and complicated relationships from the DED dataset. To ensure essential feature identification, the ESAE minimizes irrelevant and redundant features. To predict the DED, the ESAE first applies FE and then implements an ODNN classifier. This method fine-tunes the ODNN framework to enhance the effectiveness of the classification. The proposed ESAE-ODNN classification system efficiently assists in the early diagnosis of DED. Combining advanced Deep Learning (DL) methods with optimization can help us understand MGD features better and sort the data with the best accuracy (96.34%). The experimental evaluation with relevant performance metrics indicates that the proposed method is efficient in diverse aspects: accurate identification, reduced complexity, and fine-tuned performance. The ESAE-ODNN's robustness in handling intricate feature indications and high-dimensional data outperforms the existing state-of-the-art techniques.

Artificial Intelligence in Dry Eye Disease: A Narrative Review

Dry eye disease (DED) is a multifactorial condition affecting millions worldwide, characterized by discomfort, visual disturbance, and potential damage to the ocular surface. The complexity of its diagnosis and management, driven by the diversity of symptoms and underlying causes, presents significant challenges to clinicians. Artificial intelligence (AI) has emerged as a transformative tool in healthcare, offering potential solutions to these challenges through its data analysis, pattern recognition, and predictive modeling capabilities. This narrative review explores the role of AI in diagnosing, treating, and managing dry eye disease. AI-driven tools such as machine learning algorithms, imaging technologies, and diagnostic platforms are examined for their ability to enhance diagnostic accuracy, personalize treatment approaches, and optimize patient outcomes. Furthermore, the review addresses the limitations of AI technologies in ophthalmology, including the need for robust clinical validation, data privacy concerns, and the ethical considerations of integrating AI into clinical practice. The findings suggest that while AI holds promise for improving the care of patients with DED, ongoing research and development are crucial to realizing its full potential.